FDA Adverse Event Death Summary report: N

ENDEAVOR ZOTAROLIMUS-ELUTING CORONARY STENT MX2

MDR report key: 1103003 · Received August 8, 2008

Report

Report Number
2953200-2008-00669
Event Type
Death
Date Received
August 8, 2008
Date of Event
July 3, 2008
Report Date
July 11, 2008
Manufacturer
MEDTRONIC CARDIOVASCULAR GALWAY
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

EVAL RESULTS: OTHER (NO FILMS, OPERATIVE OR AUTOPSY REPORTS PROVIDED). (SUBACUTE THROMBOSIS). CONCLUSION: (NO FILMS, OPERATIVE OR AUTOPSY REPORTS PROVIDED).

Description of Event or Problem · 1

A 3.5MM DIAMETER X 18MM LENGTH ENDEAVOR MX2 DRUG-ELUTING CORONARY STENT SYSTEM WAS IMPLANTED INTO A PT FOR THE TREATMENT OF A PROXIMAL CIRCUMFLEX LESION (MDR#2953200-2008-00667). DURING PRE-PROCEDURAL DIAGNOSTIC, TWO LESIONS WERE FOUND IN THE PROXIMAL LAD AND PROXIMAL CIRC. AN ENDEAVOR 3.5 X 18MM WAS PLACED IN THE PROXIMAL CIRC. DURING INFLATION THE STENT MOVED A FEW MM MORE PROXIMAL CLOSER TO THE OSTIUM OF THE LEFT MAIN. AN ENDEAVOR 3.0X 9MM DRUG-ELUTING STENT WAS PLACED IN THE PROXIMAL LAD (MDR#2953200-2008-00668). KISSING BALLOON TECHNIQUE WAS USED TO ASSURE PROPER SIZING. AFTER FURTHER REVIEW IT WAS FOUND THAT THE FIRST ENDEAVOR DRUG-ELUTING STENT (3.5X18MM) DID NOT COVER THE ENTIRE LESION AND A SECOND 3.5 X 9MM ENDEAVOR STENT WAS PLACED DISTAL TO THE FIRST ENDEAVOR DRUG-ELUTING STENT. ALL VESSELS WERE PATENT AND A GOOD ANGIOGRAPHIC RESULT WAS ACHIEVED. IT WAS REPORTED THAT THE PT WAS RELEASED FROM THE HOSPITAL THREE DAYS LATER. THE PT COMPLAINED OF CHEST PAIN LATER THAT NIGHT AND RETURNED TO THE HOSPITAL. A SECOND PROCEDURE SHOWED POSITIVE THROMBUS IN ONE VESSEL. THE PT LATER DIED OF CARDIOGENIC SHOCK.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR ZOTAROLIMUS-ELUTING CORONARY STENT MX2 NIQ MEDTRONIC CARDIOVASCULAR GALWAY NA 0000610537

Patients

Seq Age Sex Outcome Treatment
1 61 YR Death